3/26
08:14 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.
Low
Report
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.
3/26
08:14 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.
Low
Report
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.
3/26
07:25 am
pvla
Rating for PVLA
Low
Report
Rating for PVLA
3/25
04:10 pm
pvla
Palvella Therapeutics initiated with a Buy at Stifel
Low
Report
Palvella Therapeutics initiated with a Buy at Stifel
3/7
05:28 pm
pvla
Rating for PVLA
Low
Report
Rating for PVLA
3/7
05:28 pm
pvla
Rating for PVLA
Low
Report
Rating for PVLA
3/7
08:40 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $50.00 price target on the stock.
Low
Report
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $50.00 price target on the stock.
3/7
08:40 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $50.00 price target on the stock.
Low
Report
Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $50.00 price target on the stock.
3/7
06:54 am
pvla
Palvella Therapeutics initiated with an Outperform at Scotiabank
High
Report
Palvella Therapeutics initiated with an Outperform at Scotiabank
3/7
06:54 am
pvla
Palvella Therapeutics initiated with an Outperform at Scotiabank
High
Report
Palvella Therapeutics initiated with an Outperform at Scotiabank
2/26
12:45 pm
pvla
Rating for PVLA
Report
Rating for PVLA
2/20
05:55 am
pvla
Rating for PVLA
High
Report
Rating for PVLA
2/20
05:19 am
pvla
Palvella Therapeutics initiated with a Buy at Canaccord
High
Report
Palvella Therapeutics initiated with a Buy at Canaccord
2/11
08:09 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Medium
Report
Palvella Therapeutics (NASDAQ: PVLA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
1/10
08:15 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Low
Report
Palvella Therapeutics (NASDAQ: PVLA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
1/3
08:00 am
pvla
Palvella Therapeutics (NASDAQ: PVLA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
High
Report
Palvella Therapeutics (NASDAQ: PVLA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.